FCC ID: 2BBZ7-TD-01A TITAN-IR & TITAN-IR PRO

Version: 1.1 4 5 13 14 15 23 25 27 30 33 8. FAQ 3 Medify, Inc. is a privately held consumer and medical device company focused on designing, 4 WWW.MEDIFYPBM.COM Treatment Area 5 LEDs 6 60 J/cm2 0C to 40C | 32F to 104 F WWW.MEDIFYPBM.COM Storing and transport temperature

-5C to 55C | 23 F to 131 F Storage and Transport Humidity Charging supply Charging port Recommended use Dimensions of the device Weight of the device 5V 2A 1 meter / 3.28 feet 2A 1*3.7V, 1500 mAh Lithium-ion 120-150 minutes / 2-2.5 hours 15 minutes 185 x 116 x 54 mm 248 g 7 more then happy to help you. concerns, from using this Device, stop using it immediately and consult your health professional. 8 WWW.MEDIFYPBM.COM use the device on people under the age of 18. use the device if you have severe acne on the forehead. 9 device. device. shine the light from the LEDs directly into your eyes or someone elses eyes. This may cause temporary loss of sight. use the device outdoors to prevent damage to the product. repairs contact customer support. use or store the device near hot surfaces. place the device in direct sunlight. F or cold (0 C|32F . 10 WWW.MEDIFYPBM.COM support. use the device if you have had a recent surgery or other surgical procedures. during use. 11 Contact our customer support. 12 WWW.MEDIFYPBM.COM 13 Improve Stress Management Improve Mental Acuity Power 5 Mode Delta Mode Theta Mode Alpha Mode Beta Mode Gamma Mode Wave 2. Turn on the device to start a treatment 14 WWW.MEDIFYPBM.COM to light. at least 24 hours. 15 16 WWW.MEDIFYPBM.COM acuity, and stress management levels. 17 days. 18 WWW.MEDIFYPBM.COM

discharge during regular use. 19 use any other cleansing Devices as these may damage the Device. 20 WWW.MEDIFYPBM.COM device in the app. 21 into the device. charging. full second. charged. device and charge the device. Charge the device. 22 WWW.MEDIFYPBM.COM 23 Team. 24 WWW.MEDIFYPBM.COM 25 26 WWW.MEDIFYPBM.COM 27 other transcranial treatments such as rTMS, TDCS, or ECT. Researchers have deduced that there 28 WWW.MEDIFYPBM.COM report. 29 Date of Manufacture. 30 WWW.MEDIFYPBM.COM 40C 0C 30%

IP22 This symbol means: Conforms to certain EC Directives on health, safety, and environmental protection standards. CE stands for"Conformit Europenne'. This symbols implies conformity to UK Directives on health, safety and environmental protection standards. UKCA stands for UK Conformity Assessed. Handle the packaging with care Restriction of hazardous substances. This symbol indicates the device can be used whe age above 18. 32 WWW.MEDIFYPBM.COM 10. FCC Statement void the users authority to operate the equipment. This equipment has been tested and found to comply with the limits for a Class B digital device, pursuant to Part 15 of the FCC Rules. These limits are designed to provide reasonable protection against harmful interference in a residential installation. This equipment generates uses and can radiate radio frequency energy and, if not installed and used in accordance with the instructions, may cause harmful interference to radio communications. However, there is no guarantee that interference will not occur in a particular installation. If this equipment does cause harmful interference to radio or television reception, which can be determined Reorient or relocate the receiving antenna. Increase the separation between the equipment and receiver. connected. 33 This device complies with part 15 of the FCC rules. Operation is subject to the following two conditions

(1)this device may not cause harmful interference, and (2) this device must accept any interference received, including interference that may cause undesired operation. The device has been evaluated to meet general RF exposure requirement.The device can be used inportable exposure condition without restriction. 11. Contact Information Medify Inc. 90292 Marina del Rey California, USA 34 WWW.MEDIFYPBM.COM

43mm TITAN-IR Medify Red light therapy unit GIN s7i9327590768 Quang pe f neeu 300K" Soe 1854 16xS40m ng aris cA] noo Seveyope tants rma3or0 ster. 1500 mAh Aaa

[5] Toot 000001 peice 30001 NO A arta re el Seer tee KCE taloetetrencotirscom rary Ms posited Fe 1P22 84mm

Medify, Inc 578 Washington Blvd, Suite 118, Marina del Rey, CA 90292, United States Federal Communications Commission Authorization and Evaluation Division Equipment Authorization Branch 7435 Oakland Mills Road Columbia, MD 21046 2023-8-1 To whom it may concer:

We, Medify, Inc, hereby certify that the equipment for which authorization is sought (FCC ID: 2BBZ7-

TD-01A) is not covered equipment prohit 2.903 of the FCC rules. ted from receiving an equipment authorization pursuant to We also certify that, as of the date of the filing of the application, we are not identified on the Covered List (https://www foc. gov/supplychain/coveredlist) as an entity producing covered equipment. By signing this form, we confirm the above and that we are aware of the application requirements listed under 2.911(b) and (d)(5) and (6). The information provided in this letter is based on the referenced rule parts of Title 47 of the CFR as well as KDB 986446 DO1 Sincerely, hay Hasningion hehed Signature Ray Harrington Chief Executive Officer Medify, Inc

Medify, Ine Add: 578 Washington Blvd, Suite 118, Marina del Rey, CA 90292, United States Date: 2023-8-1 FCC ID: 2BBZ7-TD-01A Dear Sir/Madam, We, Medify, Inc Hereby declares the following statement for Federal Communications Commission, all the models are electrical identical including the same software parameter and hardware design (i.e., circuit design, PCB Layout, RF module/circuit, antenna type(s) and antenna location, components on PCB, etc.,), same mechanical structure and design (including product enclosure, materials, etc.,), the only difference is the led lamp wavelength specifications are not the same, the number is not the same. Product name: TITAN-IR & TITAN-IR PRO Model no.: TD-01A, TD-01B Sincerely, hay farniington AAA Name(Title: Ray Harrington/Chief Executive Officer Company: Medify, Inc Address: 578 Washington Blvd, Suite 118, Marina del Rey, CA 90292, United States Phone: 808-495-0001 Fax: 808-495-0001 E-Mail: support@medifypbm.com

CONFIDENTIALITY REQUEST for Certification Service in USA Federal Communication Commission Equipment Authorization Division, Application Processing Branch 7435 Oakland Mills Road Columbia, MD 21046 Date:<2023-8-1>

Pursuant to Paragraphs 0.457 and 0.459 of the Commission's Rules (47 C.F.R.) and Section 552(b)(4) of the Freedom of Information Act, we requests confidentiality for the following products:

FCC ID Model name 2BBZ7-TD-01A TD-O1A For the product stated above, we request that the following information be held confidential;

Long-Term Exhibits Confidentiality Short-Term Confidentiality Short-Term Confidentiality Days Extemal Photos Internal Photos. Block Diagram Schematics Test Setup Photos:

User's Manual Parts List Tune Up moOooARRoo Operational Descriptions:

Dopooo0ol The long-term confidentiality exhibits contain our trade secrets and proprietary information that could be of benefit to our competitors. The short-term confidentiality on the basis of ensuring that business sensitive information remains confidential until the actual marketing of our new device. If you have any questions, please feel free to contact me at the address shown below. Lay Hasasngion toed Ray Harrington/ Chief Executive Officer Medify, Inc 578 Washington Blvd, Suite 118, Marina del Rey, CA 90292, United States 808-495-0001 808-495-0001 support@medifypbm.com

Medify, Ine 578 Washington Blvd, Suite 118, Marina del Rey, CA 90292, United States Federal Communications Commission Authorization and Evaluation Division Equipment Authorization Branch 7435 Oakland Mills Road Columbia, MD 21046 2023-8-1 To whom it may concer:

We, the undersigned, hereby authorize Eurofins Product Service GmbH to act.on our behaffin all matters relating to applications for equipment authorization FCC ID: 2BBZ7-TD-01A including the signing of all documents related to these matters. Any and all acts carried out by Eurofins Product Service GmbH on our behalf shall have the same effect as acts of our own. By signing this application form, we agree to Eurofins current valid General Terms and Conditions

(AGB),Testing and Certification Regulations (PZO) which can be viewed on following website www.eurofins de/ee or retrieved on request. We also hereby certify that no party to this application is subject to a denial of benefits, including FCC benefits, pursuant to Section 5301 of the Anti-Drug Abuse Act of 1988, 21 U.S.C. 862. Sincerely, hay Narningion SEGA Name/Title: Ray Harrington/Chief Executive Officer Company: Medify, Inc Address: 578 Washington Blvd, Suite 118, Marina del Rey, CA 90292, United States Phone: 808-495-0001 Fax: 808-495-0001 E-Mail: support@medifypbm.com

Medify, Inc Federal Communications Commission Authorization and Evaluation Division Equipment Authorization Branch 7435 Oakland Mills Road Columbia, MD 21046 U.S. Agent Designation 07/28/2023

[Medify, Inc] acknowledges their consent for the following contact located in the United States to act as their agent for service of process for the equipment for which authorization is sought

(FCC ID: 2BBZ7-TD-01A):

Name and company of U.S. agent: Medify, Inc Physical U.S. address of agent: 578 Washington Blvd, Suite 118, Marina del Rey, CA 90292 FRN of U.S. agent: 0033993437 Email address of U.S. agent: support@medifypbm.com

[Medify, Inc] acknowledges their obligation to accept service of process on behalf of [Medify, Inc].

[Medify, Inc] with the FRN [0033993437] accepts its obligation to maintain an agent for service of process in the United States for no less than 3 year after either the grantee has permanently terminated all marketing and importation of the applicable equipment within the U.S., or the conclusion of any Commission-related administrative or judicial proceeding involving the equipment, whichever is later. By signing this form, we confirm the above and that we are aware of the application requirements listed under 2.911(d)(7). Sincerely, Signature

[Ray Harrington]

[Chief Executive Officer]

[Medify, Inc]

Signature

[Ray Harrington]

[Chief Executive Officer]

[Medify, Inc]

4 0 V

, U

) 7

) d

1 1 9

. 2 _ t n e g A _ S U

l e d o m

_ 8 4 The information provided in this letter is based on the referenced rule parts of Title 47 of the CFR as well as KDB 986446 D01. An expiration date for this letter does not exist. In case the U.S. agent changes, the grantee is obligated to notify the FCC within 30 days via the granting TCB.